Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul F. Jacobson Insider Profile
4 Followers
Paul F. Jacobson, Director at Progenics, holds 125.60K shares in Progenics (Ticker: PGNX), holds 3.94M shares in Thorne HealthTech (Ticker: THRN). Most recently, Paul F. Jacobson ― shares of Progenics on ― for an estimated value of ―.
Paul F. Jacobson Progenics (PGNX)Director
Progenics (PGNX)
Director
Not Ranked
Paul F. Jacobson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Paul F. Jacobson does not currently own shares as a corporate insider.
A breakdown of Paul F. Jacobson's holdings
Insider Roles
Paul F. Jacobson does not currently hold a role as a corporate insider.
Roles that Paul F. Jacobson holds in companies
Most Profitable Insider Trade
Stock:
Thorne HealthTech
(THRN)
(THRN)
Rating:Informative Buy
Date:Apr 04, 2022 - Apr 04, 2023
Return:-28.20%
The most profitable trade made by Paul F. Jacobson
Paul F. Jacobson's Trading History
Progenics
―
―
―
$514.96K
Thorne HealthTech
Jul 03, 2023
―
Uninformative Sell
―
$40.15M
List of latest transactions for each holding click on a transaction to see Paul F. Jacobson's performance on stock
You May Also Like
Paul F. Jacobson insider profile FAQ
What is the percentage of profitable transactions made by Paul F. Jacobson?
The percentage of profitable transactions made by Paul F. Jacobson is ―.
What is the average return per transaction made by Paul F. Jacobson?
The average return per transaction made by Paul F. Jacobson is ―.
What stocks does Paul F. Jacobson hold?
Paul F. Jacobson holds: PGNX, THRN stocks.
What was Paul F. Jacobson’s latest transaction?
Paul F. Jacobson latest transaction was an Uninformative Buy of ―.
What was Paul F. Jacobson's most profitable transaction?
Paul F. Jacobson’s most profitable transaction was an Informative Buy of THRN stock on April 4, 2022. The return on the trade was -28.20%.
What is Paul F. Jacobson's role in Progenics?
Paul F. Jacobson's role in Progenics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.